Nutex Health reports Q3 EPS $7.76 vs. ($1.72) last year

Reports Q3 revenue $267.8M, consensus $213.81M. “We are continuing to add to a record year with 225% revenue growth, Adjusted EBITDA attributable to Nutex Health (NUTX) of $243.0M, a 629% increase in gross profit and a record high cash balance of $166.0M. Our financial performance highlights the strength of the business model with our strong balance sheet positioning us well for our planned growth strategy,” stated CFO Jon Bates. “We are very pleased to deliver another successful and profitable quarter. With the audit revisions and related activities behind us, our team is fully focused on driving future growth both within existing operations and through new facilities. Our pipeline remains strong, reflecting continued demand for small hospitals across the country,” stated CEO Tom Vo.